Location History:
- Gauting, DE (2009 - 2015)
- Munich, DE (2020)
Company Filing History:
Years Active: 2009-2020
Title: The Innovations of Patrick Bäuerle
Introduction
Patrick Bäuerle is a notable inventor based in Gauting, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of binding constructs for therapeutic applications. With a total of four patents to his name, Bäuerle's work is at the forefront of medical innovation.
Latest Patents
Among his latest patents is the invention of multispecific deimmunized CD3-binders. This invention provides a cytotoxically active CD3 specific binding construct that includes a first domain specifically binding to human CD3 and an Ig-derived second binding domain. Additionally, it encompasses a nucleic acid sequence encoding this binding construct, vectors, and host cells that contain the nucleic acid sequence. The invention also outlines a process for producing the construct and its use in pharmaceutical compositions for treating specific diseases. Another significant patent involves human-anti-human CD3 binding molecules, which details a method for preparing a human binding molecule that specifically binds to the human CD3 complex.
Career Highlights
Patrick Bäuerle has worked with prominent companies in the biotechnology sector, including Amgen Research (Munich) GmbH and Micromet AG. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Throughout his career, Bäuerle has collaborated with notable professionals in the field, including Birgit Kohleisen and Christian Itin. These collaborations have likely enhanced his research and development efforts.
Conclusion
Patrick Bäuerle's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in therapeutic treatments.